Not losing weight at any cost – but losing weight healthily. The so-called “weight loss injection” is on everyone’s lips. At SmartPraxis in Munich-Nymphenburg, we don’t offer a lifestyle product – we offer a structured, medically supervised care program with Mounjaro® (tirzepatide) and Wegovy® (semaglutide) – focused on fat loss, preservation of muscle mass, and your long-term success. #gettinghealthy #stayinghealthy #reallysmart

Many patients are currently interested in modern medical options for weight reduction. Understandably so – reports about the “weight loss injection” are everywhere. But there is something fundamental that matters to us:
It’s not about short-term solutions for us, but about safe and sustainable weight reduction with a focus on fat loss and preservation of muscle mass. Treatments with Mounjaro® (tirzepatide) and Wegovy® (semaglutide) are particularly suited for people with overweight or obesity for whom conventional measures alone have not been sufficiently successful.
We will work with you to determine whether the treatment is medically appropriate for you during a detailed initial consultation. Because the therapy is not a lifestyle product and not a “quick weight loss fix”– it is a medical treatment that must be supervised by a physician. That’s why at SmartPraxis we rely on a structured program with regular check-ups, personal support, and modern body composition analysis.
Transparency is important to us: you should know from the start what to expect. Our care concept consists of three closely integrated components.
The process begins with a detailed conversation with one of our physicians. Together, we discuss:
Before your appointment, we ask you to fill out our digital informed consent form – this gives us more time during the consultation for your questions.
A successful therapy requires continuity. That’s why monthly medical consultations take place during the treatment. This allows us to:
The monthly consultations are a mandatory component of our care concept – not as a hurdle, but for your safety.
Cost of the initial consultation: approx. €40 (in accordance with GOÄ).
Cost of monthly consultations: approx. €11 · For HZV patients, this fee is waived.
Our goal is not simply “less weight,” but healthy fat loss while preserving as much muscle mass as possible.. That’s why we regularly perform BIA measurements (bioimpedance analysis). Among other things, we analyze:
At least once per quarter a BIA measurement is mandatory Additional check-ups are possible at any time and often advisable. The follow-up assessments help us evaluate changes objectively and tailor your therapy individually.
Cost per BIA measurement: €26.54 (mandatory at least once per quarter)
The therapy is carried out exclusively under medical supervision. carried out. A prescription is only issued when the agreed check-up appointments have been kept and the treatment can be continued in a medically appropriate manner.
In certain situations, a therapy may also be discontinued – for example in the case of:
For us, this is part of responsible medicine: your health always takes priority.
Treatment with Mounjaro® and Wegovy® for weight reduction is currently not covered by statutory health insurance and is provided as an individual health service (IGeL). The medication is prescribed exclusively via a private prescription.

We see modern medications like Mounjaro® and Wegovy® not as a standalone solution, but as support on the path to a healthier lifestyle.. That’s why we combine the therapy with:
Because long-term health is more than just weight loss.
Would you like to find out whether the weight loss injection is right for you? Book your appointment – conveniently online or by phone.
Yes. Our weight loss program is open to both existing patients and new patients. Simply book an initial consultation – there, we’ll determine together whether the treatment makes medical sense for you.
No, monthly consultations without BIA analysis can easily be conducted via video.
We issue a follow-up prescription when the agreed check-up appointments have been kept and the treatment can be continued in a medically appropriate manner. Specifically, this means: regular monthly consultations and a BIA measurement at least once per quarter. Once these follow-up assessments have been completed, you will receive your private prescription during the follow-up consultation.
No. Treatment with Mounjaro® and Wegovy® for weight reduction is currently not covered by statutory health insurance. It is provided as an individual health service (IGeL), and the medication is prescribed via a private prescription.
The therapy is a medical treatment that must be supervised by a physician. The regular appointments serve your safety: we monitor tolerability, adjust the dosage, detect side effects early, and evaluate the course of treatment together with you.
Because the scale alone doesn’t tell enough. We are focused on healthy fat loss while preserving as much muscle mass as possible. The BIA makes visible how body fat, muscle mass, and water balance are actually changing – allowing us to guide the therapy objectively and individually.
Particularly for people with overweight or obesity for whom conventional measures alone have not been sufficiently successful. Whether the treatment is appropriate in your case is something we decide together during the initial consultation.
Yes. A therapy may be discontinued, for example in the case of lack of therapeutic success, significant muscle loss, intolerability, or missed follow-up assessments. Your health always takes priority.
During the initial consultation, we provide you with well-founded advice on nutrition, exercise, and muscle building. Under certain conditions, we prescribe a DIGA (prescription app) for weight loss.
Klicken Sie auf den unteren Button, um den Inhalt von app.arzt-direkt.de zu laden.